Lehmann K - Search Results

1

Prostate cancer screening: results of a prospective trial in Canton Aargau, Switzerland.

Kwiatkowski M, Huber A, Moschopulos M, Lehmann K, Wernli M, Häfeli A, Recker F. Kwiatkowski M, et al. Among authors: lehmann k. Swiss Med Wkly. 2004 Oct 2;134(39-40):580-5. doi: 10.4414/smw.2004.10533. Swiss Med Wkly. 2004. PMID: 15592949 Free article. Clinical Trial.

2

Prospective detection of clinically relevant prostate cancer in the prostate specific antigen range 1 to 3 ng./ml. combined with free-to-total ratio 20% or less: the Aarau experience.

Recker F, Kwiatkowski MK, Huber A, Stamm B, Lehmann K, Tscholl R. Recker F, et al. Among authors: lehmann k. J Urol. 2001 Sep;166(3):851-5. J Urol. 2001. PMID: 11490232 Clinical Trial.

3

Features and preliminary results of prostate cancer screening in Canton Aargau, Switzerland.

Kwiatkowski M, Huber A, Stamm B, Lehmann K, Wernli M, Häfeli A, Recker F. Kwiatkowski M, et al. Among authors: lehmann k. BJU Int. 2003 Dec;92 Suppl 2:44-7. doi: 10.1111/j.1465-5101.2003.04395.x. BJU Int. 2003. PMID: 14983954 Clinical Trial.

4

The 80-W KTP GreenLight laser vaporization of the prostate versus transurethral resection of the prostate (TURP): adjusted analysis of 5-year results of a prospective non-randomized bi-center study.

Guo S, Müller G, Lehmann K, Talimi S, Bonkat G, Püschel H, Gasser T, Bachmann A, Rieken M. Guo S, et al. Among authors: lehmann k. Lasers Med Sci. 2015 Apr;30(3):1147-51. doi: 10.1007/s10103-015-1721-x. Epub 2015 Feb 20. Lasers Med Sci. 2015. PMID: 25698433 Clinical Trial.

5

Prognostic value of urokinase plasminogen activator for prostatic carcinoma.

Lehmann K, Plas E, Gautschi K, Hauri D. Lehmann K, et al. Urol Int. 1994;52(3):159-61. doi: 10.1159/000282597. Urol Int. 1994. PMID: 7515534

6

Comparison of potassium-titanyl-phosphate laser vaporization of the prostate and transurethral resection of the prostate: update of a prospective non-randomized two-centre study.

Ruszat R, Wyler SF, Seitz M, Lehmann K, Abe C, Bonkat G, Reich O, Gasser TC, Bachmann A. Ruszat R, et al. Among authors: lehmann k. BJU Int. 2008 Nov;102(10):1432-8; discussion 1438-9. doi: 10.1111/j.1464-410X.2008.07905.x. Epub 2008 Jul 29. BJU Int. 2008. PMID: 18671785

7

[PSA in prostatic fluid].

Lehmann K, Simmler F, Schmucki O, Hauri D. Lehmann K, et al. Urologe A. 1994 May;33(3):232-4. Urologe A. 1994. PMID: 7519804 German.

8

Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): a prospective bi-centre study of perioperative morbidity and early functional outcome.

Bachmann A, Schürch L, Ruszat R, Wyler SF, Seifert HH, Müller A, Lehmann K, Sulser T. Bachmann A, et al. Among authors: lehmann k. Eur Urol. 2005 Dec;48(6):965-71; discussion 972. doi: 10.1016/j.eururo.2005.07.001. Epub 2005 Jul 18. Eur Urol. 2005. PMID: 16126327 Clinical Trial.

9

Urinary level of nuclear matrix protein 22 in the diagnosis of bladder cancer: experience with 130 patients with biopsy confirmed tumor.

Casella R, Huber P, Blöchlinger A, Stoffel F, Dalquen P, Gasser TC, Lehmann K. Casella R, et al. Among authors: lehmann k. J Urol. 2000 Dec;164(6):1926-8. J Urol. 2000. PMID: 11061883

10

Lack of diagnostic tools to prove erectile dysfunction: consequences for reimbursement?

Lehmann K, Eichlisberger R, Gasser TC. Lehmann K, et al. J Urol. 2000 Jan;163(1):91-4. J Urol. 2000. PMID: 10604322 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,124 results

Search Page

Filters